Sign up
Pharma Capital

Milestone for Optibiotix with first sales in Germany of LPLDL capsules

Stephen O'Hara, chief executive of OptiBiotix Health plc (LON:OPTI) tells Proactive they've reached a significant milestone with first sales in Germany of a new range of cholesterol-lowering capsules containing their breakthrough LP-LDL technology.

 

View full OPTI profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.